Arnebin-1 promotes angiogenesis by inducing eNOS, VEGF and HIF-1α expression through the PI3K-dependent pathway.

Area of Science:

• Biochemistry and Molecular Biology
• Pharmacology
• Regenerative Medicine

Background:

• Arnebin-1, a naphthoquinone from Zicao, is known for wound healing properties.
• Arnebin-1 and VEGF show synergistic pro-angiogenic effects on endothelial cells, aiding diabetic wound healing.
• The precise mechanisms of Arnebin-1's pro-angiogenic and wound healing effects remain unclear.

Purpose of the Study:

• To elucidate the mechanisms behind Arnebin-1's pro-angiogenic effects on human umbilical vein endothelial cells (HUVECs).
• To investigate Arnebin-1's role in accelerating diabetic wound healing.
• To determine the involvement of VEGF receptor 2 (VEGFR2) and PI3K signaling pathways.

Main Methods:

• Western blot analysis to assess VEGFR2 and PI3K pathway activation in VEGF-treated HUVECs.
• In vitro assays (MTT, Transwell, tube formation) to evaluate HUVEC proliferation, migration, and tube formation.
• Western blot and immunofluorescence staining to measure HIF-1α, eNOS, VEGF, and CD31 expression in HUVECs and rat wound tissues.

Main Results:

• Arnebin-1 enhanced VEGF-induced VEGFR2 signaling pathway activation.
• Arnebin-1 promoted HUVEC proliferation, migration, and tube formation via the PI3K-dependent pathway.
• Arnebin-1 increased eNOS, VEGF, and HIF-1α expression and accelerated diabetic wound healing, with enhanced CD31 expression.

Conclusions:

• Arnebin-1 promotes angiogenesis in HUVECs by activating the VEGFR2 and PI3K/eNOS signaling pathways.
• Arnebin-1 accelerates diabetic wound healing by enhancing pro-angiogenic factors and endothelial cell function.
• The findings highlight Arnebin-1's therapeutic potential for diabetic wound management.